Stronger together

Membership

Membership includes all the major nuclear medicine tracer companies as well as the equipment manufacturers and a few contrast media players. Admission of new Members shall be by resolution of the Members of the Grouping in accordance with Article 11 (xi) (e) from Nuclear Medicine Europe statutes.

Each and every member shall be a company or firm within the meaning of the second paragraph of Article 58 of the Treaty of Rome, and shall be active in the field of Medical Imaging and/or of Nuclear Medicine. A company cannot be a member if it has an interest of 50 % or more in the capital of another member company or if its capital is owned at the rate of 50 % or more by another member company.

If you are interested in joining the Nuclear Medicine Europe membership, please contact us directly :

Advanced Accelerator Applications

France
Visit Website

Curium

France
Visit Website

Eczacıbaşı Monrol

Romania
Visit Website

Eli Lilly

France
Visit Website

General Electric Healthcare

United Kingdom
Visit Website

IBA - Ion Beam Applications

Belgium
Visit Website

Institute For Radioelements

Institute For Radioelements

Belgium
Visit Website

Trasis

Belgium
Visit Website

Oranomed

France
Visit Website

Orano

France
Visit Website

PMB Alcen

France
Visit Website

Lantheus Medical Imaging

United Kingdom
Visit Website

Medi-radiopharma Ltd.

Hungary
Visit Website

Radiopharma Logistics Group

France
Visit Website

Siemens Healthcare GmbH

Germany
Visit Website

Comecer

Italy
Visit Website

Shine Medical

The Netherlands
Visit Website

Arronax

France
Visit Website

Janssen-Cilag International

Netherlands
Visit Website

Bayer AG Pharmaceuticals

Germany
Visit Website

TEMA Sinergie

Italy
Visit Website

Framatome

France
Visit Website

Blue Earth Diagnostics

United Kingdom
Visit Website

Jubilant Radiopharma

United Kingdom
Visit Website

Swan Isotopen

Switzerland
Visit Website

Rotem Industries Ltd

Israel
Visit Website

TELIX Pharmaceuticals

Belgium
Visit Website

Eckert & Ziegler

Germany
Visit Website

Nucleis

Belgium
Visit Website

National Centre for Nuclear Research Radioisotope Centre POLATOM

Poland
Visit Website

PDRadiopharma Inc.

Japan
Visit Website

Ariceum Therapeutics

Germany
Visit Website

QSA Global

USA
Visit Website

Radiopharm Theranostics

Australia
Visit Website

Nihon Medi Physics

Japan
Visit Website

Artbio

Switzerland
Visit Website

Cardinal Health

USA
Visit Website

RegulaNova

Switzerland
Visit Website

PanTera

Belgium
Visit Website

Serac Life Sciences

United Kingdom
Visit Website

Australian Nuclear Science and Technology Organisation

Australia
Visit Website

Nuclear Research and Consultancy Group

Netherlands
Visit Website

Centrum výzkumu Řež

Czech Republic
Visit Website

Comisión Nacional de Energía Atómica

Argentina
Visit Website

National Centre for Nuclear Research

Poland
Visit Website

Studiecentrum voor kernenergie / Centre d’étude de l’Énergie Nucléaire

Belgium
Visit Website

Commissariat à l’Energie Atomique et aux Energies Alternatives

Saclay, France
Visit Website

Japan Radioisotope Association

Japan
Visit Website

NTP Radioisotopes SOC Limited

South Africa
Visit Website

Atlanpole Technische Universität MünchenBiotherapies

Germany
Visit Website

“Nuclear Medicine Europe” – “NMEU” European Economic Interest Grouping (EEIG)
Avenue Louise 65, box 11 – 1050 Brussels (Belgium) Registration number:0443.242.686
Coordinated version after GA of 25th June 2021

BY-LAWS

INTERPRETATION

The term “Nuclear Medicine” shall mean medical activity using radioactive substances and/or related compounds. The term “Medical Imaging” shall mean medical activity aiming at the identification of anatomic and / or functional structures.

The term “Regulation” shall mean Council Regulation (EEC) No. 2137/85 of July 25, 1985 on the European Economic Interest Grouping (EEIG).

The term “Grouping” shall mean “Nuclear Medicine Europe” (“NM-EU”) EEIG. (GA 22.05.2019)

Download the complete statutes of Nuclear Medicine Europe

Shopping Basket